Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Pulmatrix, Inc. (PULM) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Pulmatrix, Inc. (PULM), most recent 12 months reported: net loss $4.01M. Latest balance sheet on file: liquid cash $2.17M. From SEC filings. Others in Pharmaceutical Preparations: PROPANC BIOPHARMA, INC. · PRAXIS PRECISION MEDICINES, INC. · Protagenic Therapeutics, Inc.\new · Petros Pharmaceuticals, Inc. · Palvella Therapeutics, Inc. · Quoin Pharmaceuticals Ltd. · Rapport Therapeutics, Inc. · Rocket Pharmaceuticals, Inc.

Stock screener

Watchlist